Rigel Pharmaceuticals
RIGL
#6624
Rank
C$1.15 B
Marketcap
C$61.37
Share price
-1.85%
Change (1 day)
2.75%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2026 (TTM): C$0.12 Billion

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are C$0.27 Billion. In 2025 the company made an earning of C$0.18 Billion, an increase over its 2024 earnings that were of C$37.58 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.12 B-31.05%
2025 C$0.18 B391.35%
2024 C$37.58 M-244.27%
2023 -C$26.06 Million-66.79%
2022 -C$78.46 Million340.73%
2021 -C$17.81 Million-56.15%
2020 -C$40.6 Million-57.34%
2019 -C$95.18 Million-7.66%
2018 -C$0.11 Billion-9.47%
2017 -C$0.12 Billion24.46%
2016 -C$91.48 Million23.63%
2015 -C$73.99 Million-43.29%
2014 -C$0.14 Billion2.5%
2013 -C$0.13 Billion
2010 C$54.13 M-133.97%
2009 -C$0.16 Billion-18.49%
2008 -C$0.2 Billion71.91%
2007 -C$0.12 Billion84.74%
2006 -C$61.56 Million-10.17%
2005 -C$68.53 Million-15.73%
2004 -C$81.32 Million39.29%
2003 -C$58.38 Million10.3%
2002 -C$52.93 Million48.3%
2001 -C$35.7 Million-2.13%
2000 -C$36.47 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
C$15.80 B 11,994.42%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$21.57 B 16,412.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-C$0.16 Billion-220.73%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI.defunct
-C$0.19 Billion-242.92%๐Ÿ‡บ๐Ÿ‡ธ USA